Evidence map›Paper›PMID 29973136›Full record

ArticleBMC cell biology2018

Caspase-independent cell death does not elicit a proliferative response in melanoma cancer cells.

Ahlima Roumane, Kevin Berthenet, Chaïmaa El Fassi, Gabriel Ichim

Open access · goldAbstract read
In one paragraph

Article in BMC cell biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ahlima RoumaneINSERM 1052, CNRS 5286, Cancer Research Center of Lyon (CRCL), Lyon, France.
Kevin BerthenetINSERM 1052, CNRS 5286, Cancer Research Center of Lyon (CRCL), Lyon, France.
Chaïmaa El FassiINSERM 1052, CNRS 5286, Cancer Research Center of Lyon (CRCL), Lyon, France.
Gabriel IchimINSERM 1052, CNRS 5286, Cancer Research Center of Lyon (CRCL), Lyon, France. gabriel.ichim@lyon.unicancer.fr.ORCID 0000-0002-8386-7405
Centre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FR

Funding

ARC Jeune Chercheur 20171206348EMBO aALTF 772-2015
6 · The paper itself

Abstract

backgroundApoptosis, the most well-known type of programmed cell death, can induce in a paracrine manner a proliferative response in neighboring surviving cells called apoptosis-induced proliferation (AiP). While having obvious benefits when triggered in developmental processes, AiP is a serious obstacle in cancer therapy, where apoptosis is frequently induced by chemotherapy. Therefore, in this study, we evaluated the capacity of an alternative type of cell death, called caspase-independent cell death, to promote proliferation.

resultsUsing a novel in vitro isogenic cellular model to trigger either apoptosis or caspase-independent cell death, we found that the later has no obvious compensatory proliferation effects on neighboring cells.

conclusionsThis study enforces the idea that alternative types of cell death such as caspase-independent cell death could be considered to replace apoptosis in the context of cancer treatment.

Indexed as

ApoptosisCaspasesCell Line, TumorCell MovementCell ProliferationHumansMelanomaModels, BiologicalCaspasesApoptosisCaspase-independent cell deathCompensatory proliferation

Identifiers

PMID29973136
PMCPMC6030751
OpenAlexW2811017312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.